BIX 02189

BIX 02189 Basic information
Product Name:BIX 02189
Synonyms:BIX 02189;(3Z)-3-[({3-[(Dimethylamino)methyl]phenyl}amino)(phenyl)methylene]-N,N-dimethyl-2-oxo-6-indolinecarboxamide;bix 2189;CS-1936;CS-39;3-(((3-((Dimethylamino)methyl)phenyl)amino)(phenyl)methylene)-N,N-dimethyl-2-oxoindoline-6-carboxamide;3-[[[3-[(Dimethylamino)methyl]phenyl]amino]phenylmethylene]-2,3-dihydro-N,N-dimethyl-2-oxo-1H-indole-6-carboxamide;(Z)-3-((3-((dimethylamino)methyl)phenylamino)(phenyl)methylene)-N,N-dimethyl-2-oxoindoline-6-carboxamide
CAS:1094614-85-3
MF:C27H28N4O2
MW:440.54
EINECS:
Product Categories:Inhibitors;MAPK
Mol File:1094614-85-3.mol
BIX 02189 Structure
BIX 02189 Chemical Properties
Melting point >250°C (dec.)
Boiling point 653.4±55.0 °C(Predicted)
density 1.230
storage temp. -20°C Freezer, Under inert atmosphere
solubility DMSO (Slightly), Methanol (Slightly)
form Solid
pka11.24±0.20(Predicted)
color Yellow
Safety Information
HS Code 2933998090
MSDS Information
BIX 02189 Usage And Synthesis
UsesBIX02189 MEK inhibitor, prevents cell proliferation and induces apoptosis. Can be applied towards treatments of cancers and proliferative cell diseases.
UsesBIX 02189 inhibits TGF-β1-induced lung cancer cell metastasis by directly targeting TGF-β type I receptor.
DefinitionChEBI: 3-[[3-[(dimethylamino)methyl]anilino]-phenylmethylidene]-N,N-dimethyl-2-oxo-1H-indole-6-carboxamide is an indolecarboxamide.
Biological Activitybix 02189 is a selective inhibitor of mek5 with ic50 value of 1.5 nm 1.bix 02189 belongs to the indolinone kinase inhibitor series. it selectively inhibited the catalytic activity of mek5 but not other closely related kinases such as mek1, mek2, erk2 and jnk2. bix 02189 also inhibited erk5 with ic50 value of 59 nm. in hela cells, treatment of bix 02189 inhibited the phosphorylation of erk5 but not erk1/2. besides that, bix 02189 prevented the transcription of the downstream substrate mef2c in hela and hek293 cells. moreover, in a three-dimensional lymphangiogenic sprouting assay, bix 02189 resulted in an inhibition of lymphangiogenic sprouting with a minimal effective concentration of 1 μm 1,2.
targetMEK5
references1. tatake r j, o’neill m m, kennedy c a, et al. identification of pharmacological inhibitors of the mek5/erk5 pathway. biochemical and biophysical research communications, 2008, 377(1): 120-125.2. schulz m m p, reisen f, zgraggen s, et al. phenotype-based high-content chemical library screening identifies statins as inhibitors of in vivo lymphangiogenesis. proceedings of the national academy of sciences, 2012, 109(40): e2665-e2674.
BIX 02189 Preparation Products And Raw materials
PLX4032 Mutant IDH1 inhibitor Tofacitinib SCH772984 CNX-1351 MS436 XMD8-92 BMS 833923 Saracatinib TG101209 CTS-1027 CCT 137690 PFK-015 LY 303511 (hydrochloride) Dimethyl sulfoxide Selumetinib TENOVIN-1 Y16

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.